SHORT TERM CLINICAL OUTCOME OF PERCUTANEOUS BALLOON MITRAL VALVULOPLASTY VERSUS SURGICAL CLOSED MITRAL COMMISSUROTOMY

Authors

  • A MOHEBBI
  • M KIAVAR
  • M MOMTAHEN From the Shahid Rajai Cardiovascular Cerner, Iran University of Medical Sciences, Tehran, Islamic Republic of Iran.
  • MB TABATABAIE
Abstract:

BaIlon mitral valvuloplasty and closed mitral valve conunissurotomy were performed in 450 and 127 patients, respectively. Also, 254 patients with severe mitral stenosis were enrolled in a prospective randomized trial comparing the two procedures. Immediately after balloon mitral valvuloplasty, mean left atrial pressure was 11.38±3.54 mmHg, transmitral valve gradient was 1.8±2 mmHg, and mitral valve area was 204± 004 cm2 (allp< 0.0001). At one week follow up after surgical mitral commissurotomy, transmitral valve gradient was 604±2o4 mmHg and mitral valve area was 1.85±Oo45 cm2. Two cases of severe mitral regurgitation occurred in each group. There was one case of death due to infection in the surgical commissurotomy group. Mild to moderate mitral regurgitation occurred in 36 patients (28.3%) in the surgical commissurotomy group whereas 11 patients (8.7%) developed only mild mitral regurgitation in the balloon commissurotomy group. The success rate was 96.8% in each group. We conclude that immediate hemodynamic results of balloon mitral commissurotomy, if not superior, is as favorable as surgical commissurotomy and is the treatment of choice in selected cases.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

short term clinical outcome of percutaneous balloon mitral valvuloplasty versus surgical closed mitral commissurotomy

bailon mitral valvuloplasty and closed mitral valve conunissurotomy were performed in 450 and 127 patients, respectively. also, 254 patients with severe mitral stenosis were enrolled in a prospective randomized trial comparing the two procedures. immediately after balloon mitral valvuloplasty, mean left atrial pressure was 11.38±3.54 mmhg, transmitral valve gradient was 1.8±2 mmhg, and mitral v...

full text

Percutaneous balloon versus surgical closed commissurotomy for mitral stenosis.

BACKGROUND We performed a prospective, randomized trial comparing percutaneous balloon commissurotomy with surgical closed commissurotomy in 40 patients with severe rheumatic mitral stenosis. METHODS AND RESULTS Data were analyzed by investigators who were masked to treatment assignment or phase of study. Patients randomized to balloon (n = 20) or surgical (n = 20) commissurotomy had severe m...

full text

Percutaneous Balloon Mitral Valvuloplasty

Balloon valvuloplasty techniques and equipment have continued to evolve over the last two decades. With this expanded experience, there has been refinement in patient selection and a clearer understanding of the benefits, limitations, and long-term results of balloon valvuloplasty. In this chapter the mechanisms, indications, techniques and clinical results of balloon valvuloplasty of the mitra...

full text

Percutaneous Balloon Mitral Valvuloplasty

Several diseases have been acknowledged as pathological causes for mitral valve stenosis (MS), of which rheumatic heart disease is the most prevalent. Rheumatic heart disease is a chronic manifestation of rheumatic carditis, which occurs in 60% to 90% of cases of rheumatic fever. Rheumatic fever is a late sequela to Group A -hemolytic streptococcal infection of the throat. The initial rheumatic...

full text

Immediate Results of Percutaneous Mitral Balloon Valvuloplasty in Patients with Mitral Stenosis

Introduction: Mitral stenosis is a prevalent valvular disease in developing countries. Percutaneous mitral balloon valvuloplasty (PMBV) is the gold standard treatment. The main objective of this study was to assess the initial results of PMBV in patients with mitral stenosis during 16 years (2002-2018) in Mashhad, Iran. Materials and Methods: From April 2002 to March 2018, 770 patients underwen...

full text

Percutaneous Balloon Mitral Valvuloplasty

Mitral stenosis (MS) is the most important long-term sequel of rheumatic fever (RF). MS is associated with deterioration of the functional status of the patients and worsens their long-term prognosis. Percutaneous balloon mitral valvuloplasty (BMV) is an effective and safe method in treating rheumatic MS when performed by an experienced operator in a carefully selected patient. A successful BMV...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 10  issue 4

pages  259- 262

publication date 1997-02

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023